Validation of physical activity levels from shank-placed Axivity AX6 accelerometers
===================================================================================

* Fatima Gafoor
* Matthew Ruder
* Dylan Kobsar

## Abstract

This cross-sectional study aimed to identify and validate cut-points for measuring physical activity using Axivity AX6 accelerometers positioned at the shank in older adults. Free-living physical activity was assessed in 35 adults aged 55 and older, where each participant wore a shank mounted Axivity and a waist mounted ActiGraph simultaneously for 72 hours. Optimized cut-points for each participant’s Axivity data were determined using an optimization algorithm to align with ActiGraph results. To assess validity between the physical activity assessments from the optimized Axivity cut-points, a leave-one-out cross validation was conducted. Bland-Altman plots with 95% limits of agreement, intraclass correlation coefficients (ICC), and mean differences were used for comparing the systems. The results indicated good agreement between the two accelerometers when classifying sedentary behaviour (ICC = 0.85) and light physical activity (ICC = 0.80), and moderate agreement when classifying moderate physical activity (ICC = 0.67) and vigorous physical activity (ICC = 0.70). Upon removal of a significant outlier, the agreement was slightly improved for sedentary behaviour (ICC = 0.86) and light physical activity (ICC = 0.82), but substantially improved for moderate physical activity (ICC = 0.81) and vigorous physical activity (ICC = 0.96). Overall, the study successfully demonstrated the capability of the resultant cut-point model to accurately classify physical activity using Axivity AX6 sensors placed at the shank.

## Introduction

Physical activity (PA) for the aging population has been identified as a protective factor for various musculoskeletal disorders and noncommunicable diseases [1]. Even with the well-known benefits of PA, many older adults are representative of the most inactive portion of the population [2]. Thus, an accurate assessment of PA can help to provide insight on the overall health and rehabilitation of the aging population. Traditionally, PA data has been collected using self-reported measures such as questionnaires, activity logs, interviews, and diaries [3]. Common PA self-report tools include the Physical Activity Scale for the Elderly (PASE), the International Physical Activity Questionnaire (IPAQ), and the Short Questionnaire to Assess Health-Enhancing Physical Activity (SQUASH) [4, 5, 6]. However, these measures are subject to recall and social desirability biases [7]. Furthermore, many have difficulties distinguishing between different PA intensities in questionnaires [8, 9]. Consequently, these subjective measures lack accuracy, as they often over- or underestimate the true levels of PA [10].

With the advent of wearable accelerometers, researchers can overcome these limitations and obtain objective measures of PA. These accelerometers can be worn outside of the lab and collect free-living data for multiple days, thereby providing a more comprehensive understanding of an individual’s PA levels [7]. Among these devices, ActiGraph devices are widely used as the gold standard for clinical and research-based PA assessment, with over 20,000 papers published on its use in the past two decades [11].

The quantification of PA levels using these devices typically involves assessing time spent in different PA intensity ranges such as sedentary behaviour (SB), light physical activity (LPA), moderate physical activity (MPA) and vigorous physical activity (VPA). This is achieved by measuring the magnitude of three-dimensional acceleration signals, known as the resultant acceleration. The resultant accelerations are then used to determine activity counts, with higher accelerations resulting in greater the number of activity counts measured per minute [7]. Subsequently, cut-points are applied to these activity counts to classify the PA intensity, delineating data into the different categories of SB, LPA, MPA, and VPA. These cut-points are specific to the wear location of the device.

The ActiGraph GT9X Link, equipped with an inertial measurement unit (IMU) including accelerometer, gyroscope, and magnetometer sensors, is one device commonly used for collecting PA data. These devices can be worn at the wrist, waist, and the ankle but require different cut-point models for each site as the level of accelerations vary between segments [12]. Therefore, deploying a sensor at any new location would require updating and validating a new set of cut-points for that placement site. While wrist, waist, and ankle placements offer sufficient flexibility for assessing PA, recent advancements in sensor capabilities, including improved data quality, higher frequency measurements, and enhanced data storage and battery life, have opened up many new possibilities for free-living PA assessments.

Most notably, wearable sensors are being increasingly used to assess free-living gait. Free-living gait gives us the opportunity to gain insight into the motion of the limbs in an ecologically valid, real-world setting, rather than a conventional gait lab. While conventional gait labs are widely used in gait research, they are highly controlled settings and may be non-representative of an individual’s daily, functional gait [13]. Axivity sensors are an example of IMU sensors that have been used in gait research surrounding physical function and disease state [14], but also possess PA assessment capability given their potential for high frequency data collections with enhanced data storage and battery life.

While there are a wide variety of placement sites used to acquire free-living gait data, a common placement to assess movement and impact accelerations near the knee is the proximal shank [15, 16, 17]. This placement site may offer insights into the progression of musculoskeletal and neurological diseases, such as knee osteoarthritis and Parkinson’s through gait assessments [18, 19]. Although this sensor placement can be ideal in assessing free-living gait, there are no methods or cut-points available to determine PA from sensors worn at this wear location. As such, obtaining concurrent PA data while measuring free-living gait would inefficiently require another sensor placed at one of the previously validated sites.

Therefore, the purpose of this study is to develop and validate cut-points for a free-living gait-capable sensor, the Axivity AX6, placed at the proximal shank by comparing it to the gold standard waist-mounted ActiGraph GT9X. It was hypothesized that the agreement of SB and LPA would be higher than the agreement of MPA and VPA. The outcomes compared between the sensors were the percentage of time spent in the different PA intensities: SB, LPA, MPA, and VPA for a total wear time of 72 hours.

## Methods

### Participants

Thirty-five adults over the age of 55 years (18F, age: 71 ± 9 years, height: 167.28 ± 9.79 cm, mass: 76.50 ± 15.10 kg, BMI: 27.00 ± 3.62 kg/m2) were recruited in this cross-sectional validation study. The inclusion criteria included anyone over the age of 55 years that could ambulate without any walking aids. Participants were recruited from the Physical Activity Centre of Excellence (PACE) at McMaster University, a centre which encourages community exercise and rehabilitation for older adults, from January 12, 2023 to March 23, 2023. All participants provided their written informed consent prior to enrolling in this study. This study was approved by the McMaster Research Ethics Board, Hamilton, ON.

### Procedures

Participants were asked to report their age, sex, height, mass. Each subject reported if they had received any lower limb injuries in the past year, had been diagnosed with osteoarthritis, and if they had received any lower limb replacement surgeries. Two wearable sensors were used to concurrently collect free-living PA data for 72 consecutive hours. The first of which was the gold standard ActiGraph GT9X (ActiGraph LLC, FL, United States) which was worn by each participant above the right iliac crest with a waistband and pouch which held the device. Participants were encouraged to ensure the pouch sat above their right hip for the full 72 hours. Participants were instructed to only take off the waistband to shower or bath, and if necessary, while sleeping, and wear it immediately upon waking and after their shower or bath. The ActiGraph was initialized to start collecting ±8g accelerometer data at 100 Hz simultaneously with the Axivity for 72 hours through the ActiLife v6.13.4 software. The ‘idle’ sleep mode in the ActiLife software was disabled for the ActiGraph sensors.

The sensor to be validated was the Axivity AX6 (Axivity Ltd, Newcastle upon Tyne, United Kingdom) which was placed below the right knee, medial and inferior to the right tibial tuberosity, of each participant using SIMPATCH adhesive patches. The Axivity accelerometer was initialized through the Open Movement software (OMGui, version 1.0.0.44) and recorded ±8g accelerometer data at 100Hz, as well as ±1000°/s gyroscope data that was not analyzed in the current study. Participants were shaved with an electric razor (Philips OneBlade, Amsterdam, Netherlands) before the sensors were placed to ensure the sensors were both comfortable and adhered to the skin well for the entirety of the 72 hours.

### Data analysis

Following the retrieval of the sensors after 72 hours of wear, the data from the ActiGraphs were downloaded and processed through the ActiLife software. Each participants’ data was categorized into SB, LPA, MPA, and VPA using the Freedson cut-points and 60-second epochs [20] which are available through the ActiLife software. The percentage of time spent in the different intensities was computed by the ActiLife software, based on the activity counts per minute. The time totalled to 72 hours for each participant.

Raw from the Axivity sensor were downloaded through the OpenMovement software (OMGui) and saved in a binary CWA file. An open-source MATLAB (MathWorks, Natick, MA, USA) script by Felix Liu [21], which uses methods published by Brønd, Andersen, and Arvidsson [22] was used to generate ActiGraph equivalent activity counts per minute from Axivity accelerometers. The activity counts for each participant were categorized into PA intensities using optimized cut-points for each participant. However, using the same cut-point values applied to the waist data would results in invalid data given the difference in acceleration signals across these sites [23]. Therefore, to optimize a new set of cut-points for the shank-placed Axivity sensor, an optimization algorithm in MATLAB was created, using the Global Optimization Toolbox [24]. Fig 1 outlines the optimization algorithm and resulting cross validation. In short, this optimization algorithm was given raw Axivity acceleration data, an initial starting set of cut-points based on pilot testing of data collected prior to this study, and the gold-standard results obtained from the ActiGraph (i.e., time spent in SB, LPA, MPA, VPA). It then sequentially optimized the cut-points for the Axivity data by first evaluating SB, then LPA, MPA, and finally VPA, resulting in three values to distinguish SB, LPA, MPA, and VPA. In other words, the optimization algorithm was given the raw data from the Axivity at the shank and asked to find the cut-points that best approximated the results from the waist-mounted ActiGraph. This optimization occurred at the individual level, resulting in 35 distinct sets of cut-points (i.e., one set for each participant). To generate a cross-validated set of cut-points that were blinded from each individual’s result, a leave-one-out cross validation (LOOCV) was applied. This involved averaging the cut-points from 34 participants (i.e. all other participants) into a single set of cut-points that could then be applied to the data of the left-out subject. Consequently, the PA data generated for each subject was solely based on the optimized results from the other 34 subjects, ensuring complete blinding to the information of the excluded subject.

![Fig 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2023/08/21/2023.08.19.23294309/F1.medium.gif)

[Fig 1.](http://medrxiv.org/content/early/2023/08/21/2023.08.19.23294309/F1)

Fig 1. Flowchart of Leave-one-out cross validation analysis.

### Statistical analysis

The agreement between the ActiGraph and the LOOCV Axivity results for each PA intensity: SB, LPA, MPA, and VPA, were assessed using Bland-Altman plots with 95% limits of agreement (LOA; mean difference of methods ±1.96 SD) [25]. Additionally, intraclass correlation coefficients (ICC; single measure, absolute agreement) with 95% confidence intervals (CIs) were computed for each intensity to measure reliability of the Axivity. The ICC values were interpreted poor (ICC < 0.5), moderate (0.5 < ICC <0.75), good (0.75 < ICC< 0.9), and excellent (ICC > 0.9) [26]. The agreement between the ActiGraph and individually optimized Axivity results were also computed, to serve as a comparison of the training data (i.e., individually optimized) versus the generalizable, cross-validated results.

## Results

Participant demographics are reported in Table 1. While 35 individuals were recruited for the study, one participants’ data was omitted from the analysis due to early removal of the Axivity sensor. Results from the training model and the LOOCV analysis are shown in Table 2. Individual results from the LOOCV analysis are shown in the Bland-Altman plots in Fig 2. The results from the optimized cut-points training model matched closely with the ActiGraph results and all intensities had excellent agreement, as expected given they are individually optimized. When performing the LOOCV analysis, results showed the SB and LPA have good reliability, with mean differences of 2.40% and 2.37%, respectively. Whereas the MPA and VPA have moderate reliability and mean differences of 0.51% and 0.10% respectively.

View this table:
[Table 1.](http://medrxiv.org/content/early/2023/08/21/2023.08.19.23294309/T1)

Table 1. Participant Demographics.

View this table:
[Table 2.](http://medrxiv.org/content/early/2023/08/21/2023.08.19.23294309/T2)

Table 2. Results.

![Fig 2.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2023/08/21/2023.08.19.23294309/F2.medium.gif)

[Fig 2.](http://medrxiv.org/content/early/2023/08/21/2023.08.19.23294309/F2)

Fig 2. Bland-Altman plot of the time spent in different PA intensities in minutes, for agreement between the Axivity and the ActiGraph in the LOOCV analysis.

After initial data analysis, a significant outlier was identified in the LOOCV analysis. Outliers were defined as data points that deviated significantly from the remaining values of the dataset, using a criterion of falling outside three standard deviations from the mean value. Based on this criterion, one participant was considered an outlier in the LOOCV dataset. In order to ensure the integrity of the results and subsequent cut-point models, a careful decision was made to exclude this outlier from the analysis. By removing this outlier from the dataset, we aimed to achieve a more representative dataset for further analysis. Following the outlier’s removal, ICCs for SB, LPA, and MPA showed good agreement, while the ICC for VPA showed excellent agreement, as depicted in Table 3. Individual results from the LOOCV analysis with the outlier removed are shown in the Bland-Altman plots in Fig 3.

View this table:
[Table 3.](http://medrxiv.org/content/early/2023/08/21/2023.08.19.23294309/T3)

Table 3. Results with outlier removed.

![Fig 3.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2023/08/21/2023.08.19.23294309/F3.medium.gif)

[Fig 3.](http://medrxiv.org/content/early/2023/08/21/2023.08.19.23294309/F3)

Fig 3. Bland-Altman plot of the time spent in different PA intensities in minutes, for agreement between the Axivity and the ActiGraph in the LOOCV analysis, with the outlier removed.

Based on these results, the resultant cut-points developed for the Axivity accelerometer, when placed below the knee, were computed as the average of the 34 participants and are shown in Table 4. Also shown in Table 4 are the cut-points after the outlier was removed, which is the more representative set of cut-points to use for accelerometers worn at the shank.

View this table:
[Table 4.](http://medrxiv.org/content/early/2023/08/21/2023.08.19.23294309/T4)

Table 4. Resultant Cut-points.

## Discussion

The purpose of this study was to determine and validate cut-points to measure PA with Axivity sensors placed at the shank in older adults. Overall, the Axivity demonstrated good agreement with the gold standard for PA assessment, the ActiGraph, when assessing SB and LPA. When classifying MPA and VPA, the Axivity showed moderate agreement with the ActiGraph. However, with outliers accounted for, MPA and VPA showed good and excellent agreement, respectively. These data demonstrated that accelerometers placed just below the knee can effectively measure an older adult’s PA. Overall, the resultant cut-points determined in this study enable the assessment of PA in older adults at the proximal shank, either independently or in conjunction with research focused on free-living gait data from this site.

Our results supported our original hypothesis which predicted that SB and LPA would have greater agreement than MPA and VPA with the ActiGraph, as the SB and LPA demonstrated ICCs of 0.85 and 0.80, respectively. Whereas the MPA and VPA intensities demonstrated ICCs of 0.67 and 0.70, respectively. This may be because participants, being older adults, did not all perform large amounts of MPA and VPA. The average percentage of time spent in VPA was 1.04 %, with 26 participants having no VPA. This likely reduced the samples of MPA and VPA collected and could have affected the average of the resultant cut-points to identify MPA and VPA. These results are consistent with previous studies that assessed PA between ActiGraph and other devices, including the Axivity, which also found greatest agreement when classifying SB and LPA over MPA, and VPA, such as the study done by Rowlands et al. [29], due to the relatively small amount of time spent in moderate and vigorous PA levels [30].

With one outlier removed, these ICCs improved to 0.86, 0.82, 0.81, and 0.96 for SB, LPA, MPA, and VPA, respectively. Upon evaluation, the recorded Axivity accelerations and subsequently derived activity counts of the outlier were substantially higher in magnitude compared to those of the remaining participants, despite the ActiGraph data of the outlier aligning with that of the other participants. Consequently, the outlier’s optimized cut-points were significantly greater than the average cut-points of all subjects. Thus, when conducting the LOOCV including the outlier’s optimized cut-points, the model overestimated the time spent in Specifically, the resultant cut-points including the outlier are higher for MPA and VPA intensities when compared to the cut-points with the outlier removed. Higher recorded or erroneous accelerations from one subject’s Axivity can be due to many potential reasons, which can include sensor movement as a result of being loosely attached and the introduction of artifacts and noise into the accelerometer readings. Nevertheless, we cannot pin-point the exact cause as to why one subject’s Axivity sensor collected greater accelerations than others’ Axivity sensors. The optimized cut-points of the outlier affected all PA intensities, however, it had a limited impact on SB and LPA data, which further highlights the quality of these outcomes in older adults compared to MPA and VPA. Despite the outlier’s removal improving the results to excellent validity, we still caution the use of VPA data in older adults moving forward, given the limited amount of data in these intensity levels.

With respect to the cut-points used for MPA and VPA, they are similar to cut-points found in a study done by Rhudy et. al. [31] which identified cut-points for the ActiGraph GT9X at varying wear-locations proximal to the shank, such as the ankle, foot, along with the wrist and hip to measure moderate and vigorous PA. These cut-points are shown in Table 5 along with the cut-points from the shank developed from the results of the current study. These wear locations offer some opportunity for comparing cut-points at proximal locations, such as the ankle and foot. Theoretically, the cut-points for the ankle and foot should be greater, as the impact accelerations experienced would be greater than those at the shank. It is also expected that the cut-points for the shank for both MPA and VPA are greater than those of the hip. This is mostly reflected in the results from Rhudy et al. and the current study, as the cut-points for MPA and VPA measured at the ankle are 14767 and 17818 counts per minute, respectively, and the cut-points for MPA and VPA measured at the foot are 20575 and 22629 counts per minute, respectively. For the current study, the cut-points for MPA and VPA measured at the shank are 8357 and 18438. As expected, these shank cut-points are greater than the cut-points for the hip for MPA and VPA, which are 4978 and 6227 counts per minute. Furthermore, the cut-point for MPA at the shank is less than the cut-points at the ankle and foot, as predicted. While the cut-point for VPA at the shank is less than the cut-point for the foot, it is greater than the cut-point at the ankle. This could be since the cut-points for the foot and ankle in the aforementioned study were identified through a young, healthy population in a controlled setting, whereas the current study’s population consisted solely of older adults in free-living conditions.

View this table:
[Table 5.](http://medrxiv.org/content/early/2023/08/21/2023.08.19.23294309/T5)

Table 5. Cut-points for MPA and VPA at foot, ankle, and hip wear locations from Rhudy et al. [31].

This study has some limitations to be discussed. Firstly, participants removing the ActiGraph sensor when showering may have influenced the results, as the Axivity was worn for the full 72 hours. This likely would have minimal influence over the results with both accelerometers likely resulting in a SB classification, as showers are typically short in duration and most people won’t move a significant amount while showering. However, if participants forgot to wear, or delayed, the placement of the ActiGraph after their shower, this could adversely affect agreement between two sensors.

Secondly, it is possible that individuals could have performed movement with their lower limbs, without moving their trunk, such as leg raises, which could have recorded more accelerations in the Axivity than the ActiGraph, if the hip-worn accelerometer was not experiencing movement. This would have impacted the final cut-points that were developed. Nevertheless, the current findings present a first step at classifying PA from shank-placed accelerometers and identifying cut-points for this wear location, which can be widely used in gait research in the elderly.

## Conclusion

These results displayed a good agreement between the gold standard ActiGraph sensors and the Axivity sensors to classify PA and SB when worn at the shank. The resultant cut-points can be used for accelerometers, including the Axivity and ActiGraph, worn specifically just below the knee at the shank. The introduction of shank cut-points are a novel contribution that will aid in simplifying concurrent PA assessments that occur in older adults also completing gait assessments.

## Data Availability

All relevant data are within the manuscript and its Supporting Information files.

## Supporting Information

**S1 Table. Participant Axivity and ActiGraph Data**. Axivity Data is missing from Participant 21 due to early removal of the Axivity AX6 sensor.

## Acknowledgements

I would like to thank the Physical Activity Centre of Excellence at McMaster University for supporting this study, as well as all the participants for their time and efforts, that made this study possible.

*   Received August 19, 2023.
*   Revision received August 19, 2023.
*   Accepted August 21, 2023.


*   © 2023, Posted by Cold Spring Harbor Laboratory

This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)

## References

1.  1.Langhammer B, Bergland A, Rydwik E. The importance of physical activity exercise among older people. BioMed Res Int. 2018;2018: 7856823. doi:10.1155/2018/7856823
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1155/2018/7856823&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=30627571&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 

2.  2.Watson KB, Carlson SA, Gunn JP, Galuska DA, O’Connor A, Greenlund KJ, et al. Physical inactivity among adults aged 50 years and older - United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65: 954–958. doi:10.15585/mmwr.mm6536a3
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.15585/mmwr.mm6536a3&link_type=DOI) 

3.  3.Martins JC, Aguiar LT, Nadeau S, Scianni AA, Teixeira-Salmela LF, Faria CDC de M. Measurement properties of self-report physical activity assessment tools in stroke: a protocol for a systematic review. BMJ Open. 2017;7: e012655. doi:10.1136/bmjopen-2016-012655
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMToiNy8yL2UwMTI2NTUiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMy8wOC8yMS8yMDIzLjA4LjE5LjIzMjk0MzA5LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

4.  4.Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA. The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol. 1999;52: 643–651. doi:10.1016/s0895-4356(99)00049-9
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0895-4356(99)00049-9&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=10391658&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000081121200008&link_type=ISI) 

5.  5.Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35: 1381–1395. doi:10.1249/01.MSS.0000078924.61453.FB
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1249/01.MSS.0000078924.61453.FB&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12900694&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000184527600020&link_type=ISI) 

6.  6.Wendel-Vos GCW, Schuit AJ, Saris WHM, Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol. 2003;56: 1163–1169. doi:10.1016/s0895-4356(03)00220-8
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0895-4356(03)00220-8&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=14680666&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000187582500007&link_type=ISI) 

7.  7.Sylvia LG, Bernstein EE, Hubbard JL, Keating L, Anderson EJ. A practical guide to measuring physical activity. J Acad Nutr Diet. 2014;114: 199–208. doi:10.1016/j.jand.2013.09.018
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jand.2013.09.018&link_type=DOI) 

8.  8.Sallis JF, Saelens BE. Assessment of physical activity by self-report: status, limitations, and future directions. Res Q Exerc Sport. 2000;71: 1–14. doi:10.1080/02701367.2000.11082780
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/02701367.2000.10608875&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=10763516&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000085789500001&link_type=ISI) 

9.  9.Timperio A, Salmon J, Crawford D. Validity and reliability of a physical activity recall instrument among overweight and non-overweight men and women. J Sci Med Sport. 2003;6: 477–491. doi:10.1016/S1440-2440(03)80273-6
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S1440-2440(03)80273-6&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=14723397&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000187667000011&link_type=ISI) 

10. 10.Prince SA, Adamo KB, Hamel ME, Hardt J, Gorber SC, Tremblay M. A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act. 2008;5: 56. doi:10.1186/1479-5868-5-56
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/1479-5868-5-56&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18990237&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 

11. 11.Neishabouri A, Nguyen J, Samuelsson J, Guthrie T, Biggs M, Wyatt J, et al. Quantification of acceleration as activity counts in ActiGraph wearable. Sci Rep. 2022;12: 11958. doi:10.1038/s41598-022-16003-x
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/s41598-022-16003-x&link_type=DOI) 

12. 12.Romero E, Neuman M, Warrington R. Kinetic energy harvester for body motion. 2009.
    
    

13. 13.Shah VV, McNames J, Mancini M, Carlson-Kuhta P, Spain RI, Nutt JG, et al. Laboratory versus daily life gait characteristics in patients with multiple sclerosis, Parkinson’s disease, and matched controls. J NeuroEngineering Rehabil. 2020;17: 159. doi:10.1186/s12984-020-00781-4
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12984-020-00781-4&link_type=DOI) 

14. 14.Powell D, Nouredanesh M, Stuart S, Godfrey A. Investigating the AX6 inertial-based wearable for instrumented physical capability assessment of young adults in a low-resource setting. Smart Health. 2021;22: 100220. doi:10.1016/j.smhl.2021.100220
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.smhl.2021.100220&link_type=DOI) 

15. 15.Li Y, Wang L. Human activity recognition based on residual network and BiLSTM. sensors. 2022;22: 635. doi:10.3390/s22020635
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/s22020635&link_type=DOI) 

16. 16.Li Q, Young M, Naing V, Donelan JM. Walking speed estimation using a shank-mounted inertial measurement unit. J Biomech. 2010;43: 1640–1643. doi:10.1016/j.jbiomech.2010.01.031
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jbiomech.2010.01.031&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20185136&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 

17. 17.Celik Y, Stuart S, Woo WL, Godfrey A. Wearable inertial gait algorithms: impact of wear location and environment in healthy and Parkinson’s populations. Sensors. 2021;21: 6476. doi:10.3390/s21196476
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/s21196476&link_type=DOI) 

18. 18.Tsukamoto H, Saito K, Saito H, Kijima H, Akagawa M, Komatsu A, et al. A novel classification of coronal plane knee joint instability using nine-axis inertial measurement units in patients with medial knee osteoarthritis. Sensors. 2023;23: 2797. doi:10.3390/s23052797
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/s23052797&link_type=DOI) 

19. 19.Morris R, Hickey A, Del Din S, Godfrey A, Lord S, Rochester L. A model of free-living gait: A factor analysis in Parkinson’s disease. Gait Posture. 2017;52: 68–71. doi:10.1016/j.gaitpost.2016.11.024
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.gaitpost.2016.11.024&link_type=DOI) 

20. 20.Freedson PS, Melanson E, Sirard J. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc. 1998;30: 777.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/00005768-199805000-00021&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9588623&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000073320900021&link_type=ISI) 

21. 21.Liu F. Axivity_AX3. 2022. Available: [https://github.com/FelixLiu-SF/Axivity\_AX3](https://github.com/FelixLiu-SF/Axivity_AX3)
    
    

22. 22.Brønd JC, Andersen LB, Arvidsson D. Generating ActiGraph counts from raw acceleration recorded by an alternative monitor. Med Sci Sports Exerc. 2017;49: 2351–2360. doi:10.1249/MSS.0000000000001344
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1249/MSS.0000000000001344&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 

23. 23.LaMunion SR, Bassett DRJ, Toth LP, Crouter SE. Effect of wear location on ActiGraph activity counts: 2286 Board #299 June 1 2: 00 PM - 3: 30 PM. Med Sci Sports Exerc. 2017;49: 643. doi:10.1249/01.mss.0000518693.36595.09
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1249/01.mss.0000518693.36595.09&link_type=DOI) 

24. 24.Optimization Toolbox version: 9.4 (R2022b), Natick, Massachusetts: The MathWorks Inc.; 2022.
    
    

25. 25.Martin Bland J,  Altman Douglas G. Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet. 1986;327: 307–310. doi:10.1016/S0140-6736(86)90837-8
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(86)90837-8&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=2868172&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 

26. 26.Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15: 155–163. doi:10.1016/j.jcm.2016.02.012
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jcm.2016.02.012&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=27330520&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom) 

27. 27.Murray DW, Fitzpatrick R, Rogers K, Pandit H, Beard DJ, Carr AJ, et al. The use of the Oxford hip and knee scores. J Bone Joint Surg Br. 2007;89-B: 1010–1014. doi:10.1302/0301-620X.89B8.19424
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NjoiamJqc2JyIjtzOjU6InJlc2lkIjtzOjExOiI4OS1CLzgvMTAxMCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzA4LzIxLzIwMjMuMDguMTkuMjMyOTQzMDkuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

28. 28.Oxford Knee Score | Auckland Surgery. [cited 13 Jul 2023]. Available: [https://www.aucklandsurgery.co.uk/navigator/oxford-knee-score/](https://www.aucklandsurgery.co.uk/navigator/oxford-knee-score/)
    
    

29. 29.Rowlands AV, Mirkes EM, Yates T, Clemes S, Davies M, Khunti K, et al. Accelerometer-assessed physical activity in epidemiology: are monitors equivalent? Med Sci Sports Exerc. 2018;50: 257. doi:10.1249/MSS.0000000000001435
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1249/MSS.0000000000001435&link_type=DOI) 

30. 30.Pfister T, Matthews CE, Wang Q, Kopciuk KA, Courneya K, Friedenreich C. Comparison of two accelerometers for measuring physical activity and sedentary behaviour. BMJ Open Sport Exerc Med. 2017;3: e000227. doi:10.1136/bmjsem-2017-000227
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3NlbSI7czo1OiJyZXNpZCI7czoxMToiMy8xL2UwMDAyMjciO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMy8wOC8yMS8yMDIzLjA4LjE5LjIzMjk0MzA5LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

31. 31.Rhudy MB, Dreisbach SB, Moran MD, Ruggiero MJ, Veerabhadrappa P. Cut points of the Actigraph GT9X for moderate and vigorous intensity physical activity at four different wear locations. J Sports Sci. 2020;38: 503–510. doi:10.1080/02640414.2019.1707956
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/02640414.2019.1707956&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F08%2F21%2F2023.08.19.23294309.atom)